MedTrace Logo

Latinos CARES (Colorectal Cancer Awareness, Research, Education and Screening)

NCT03078361 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 159

Last updated 2023-01-11

No results posted yet for this study

Summary

The purpose of this study is to conduct 4 focus groups and recruit for 12 participants per focus group to explore community members' views about colorectal cancer screening (CRCS) processes and perceived benefits and impediments, what information they believe should be communicated, communication preferences (style, tone) and perceptions of screenings.

Conditions

Interventions

OTHER

Immunochemical Fecal Occult Blood Test (I-FOBT) Kit

Both intervention groups will receive an I-FOBT kit (by study coordinator) with verbal and written instructions in Spanish on how to complete the stool sampling at home within 1 week, and mail the completed kit in the pre-addressed, postage paid mailer. Patients with abnormal results will receive a call explaining the meaning of an abnormal I-FOBT and encouraging them to take specific next steps.

BEHAVIORAL

LATINOS CARES Toolkit

DVD + photonovella booklet), about colorectal cancer screening (CRCS) targeted for a Latino medically underserved population.

BEHAVIORAL

Standard Intervention

Standard intervention (CDC brochure) on colorectal cancer screening in community health clinics.

Sponsors & Collaborators

  • Florida Department of Health

    collaborator OTHER_GOV

  • Bankhead-Coley Cancer Research Program

    collaborator UNKNOWN

  • H. Lee Moffitt Cancer Center and Research Institute

    lead OTHER

Principal Investigators

  • Clement Gwede, Ph.D. · H. Lee Moffitt Cancer Center and Research Institute

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-04-28
Primary Completion
2016-07-14
Completion
2022-10-26

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03078361 on ClinicalTrials.gov